Osteoradionecrosis After Modern Radiotherapy for Oral Cavity Cancer: Incidence and Risk Factors
Laryngoscope Investigative Otolaryngology · 2026-06 · 11 (3)
DOI: 10.1002/lio2.70431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laryngoscope Investigative Otolaryngology, online erschienen am 06.05.2026. Verfasst von Alyssa Farley und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology University of Cincinnati Cincinnati Ohio USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
Osteoradionecrosis (ORN) incidence after head and neck cancer (HNC) directed radiation therapy has recently been reported to be 1%–40%. The objective of this study is to establish contemporary incidence of ORN for patients treated with IMRT exclusively for oral cavity squamous cell carcinoma (OCSCC).
Methods
This study is a retrospective chart review of 172 patients treated for OCSCC at a single institution from 2013 to 2022. All patients received adjuvant radiation with or without chemotherapy. Patient charts were reviewed to identify ORN. ORN was defined as exposure of bone with radiographic findings and/or physical exam findings. Data collected including age, gender, smoking status, AJCC 8th edition stage, mandibulectomy or maxillectomy as part of surgery, hospitalization in between surgery and RT, and concurrent chemotherapy.
Results
Mean follow up for the entire cohort was 46.1 months. The incidence of ORN in our cohort of patients was 24% at 3 years. 51.5% of patients underwent mandibulectomy or maxillectomy prior to radiation. 28.4% of patients with mandibulectomy or maxillectomy developed ORN. 18.1% of the patients treated without mandibulectomy or maxillectomy went on to develop ORN. Hazard ratio for development of ORN when patients underwent mandibulectomy or maxillectomy was 1.93.
Conclusion
ORN development is higher in oral cavity SCC when compared to published ORN rates in mixed HNC cohorts. Mandibulectomy and/or maxillectomy as part of surgical treatment for OCSCC increases risk for ORN development. Level of Evidence Level 3.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology University of Cincinnati Cincinnati Ohio USA.
ORCID-Profile: Jordan Kharofa, Vinita Takiar
Zitieren
APA
Farley, A., Petery, T., Dick, N., Sackett, J., Kharofa, J., & Takiar, V. (2026). Osteoradionecrosis After Modern Radiotherapy for Oral Cavity Cancer: Incidence and Risk Factors. Laryngoscope Investigative Otolaryngology, 11(3). https://doi.org/10.1002/lio2.70431
Vancouver
Farley A, Petery T, Dick N, Sackett J, Kharofa J, Takiar V. Osteoradionecrosis After Modern Radiotherapy for Oral Cavity Cancer: Incidence and Risk Factors. Laryngoscope Investigative Otolaryngology. 2026;11(3). doi:10.1002/lio2.70431
BibTeX
@article{Farley2026,
author = {Farley, Alyssa and Petery, Taylor and Dick, Nigel and Sackett, Jonathan and Kharofa, Jordan and Takiar, Vinita},
title = {Osteoradionecrosis After Modern Radiotherapy for Oral Cavity Cancer: Incidence and Risk Factors},
journal = {Laryngoscope Investigative Otolaryngology},
year = {2026},
volume = {11},
number = {3},
doi = {10.1002/lio2.70431}
}
EUVIMED